title: Irinotecan (CPT-11) in the treatment of mycosis fungoides.
authors.forename: T
authors.initials: T
authors.lastname: Yokote
authors.forename: T
authors.initials: T
authors.lastname: Akioka
authors.forename: S
authors.initials: S
authors.lastname: Oka
authors.forename: T
authors.initials: T
authors.lastname: Yamano
authors.forename: S
authors.initials: S
authors.lastname: Hara
authors.forename: K
authors.initials: K
authors.lastname: Higashi
authors.forename: U
authors.initials: U
authors.lastname: Enomoto
authors.forename: H
authors.initials: H
authors.lastname: Kusakabe
authors.forename: K
authors.initials: K
authors.lastname: Kiyokane
authors.forename: M
authors.initials: M
authors.lastname: Tsuji
authors.forename: T
authors.initials: T
authors.lastname: Hanafusa
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D002166:Camptothecin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D000077146:Irinotecan; D008297:Male; D008875:Middle Aged; D009182:Mycosis Fungoides / Q000188:drug therapy*; D012878:Skin Neoplasms / Q000188:drug therapy*
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D000077146:Irinotecan; D002166:Camptothecin